Panobinostat Lactate (Jan) | All | Licensing, EU CTD Dossiers, Formulation Suppliers

Panobinostat lactate [JAN]

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

2 Suppliers, 1 USDMF, 2 EU WC, 1 NDC API, 1 Listed Suppliers

DEVELOPMENTS

7 Drug(s) in Development

7 Drug(s) in Development

DOSSIERs // Finished Dosage Forms

3 Dossiers, 3 FDA Orange Book

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 10MG BASE, CAPSULE;ORAL - EQ 15MG BASE, CAPSULE;ORAL - EQ 20MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 16 SPI Pharma, 15 Roquette, 9 Microlex e.U, 8 Gangwal Healthcare, 8 Sigachi Industries, 6 Kerry, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Ingredion Pharma Solutions, 3 Gangwal Chemicals, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Prachin Chemical, 2 DFE Pharma, 2 Vasa Pharmachem, 1 Ideal Cures Pvt Ltd, 1 Pfanstiehl, 1 Pharmatrans-Sanaq, 1 DKSH, 1 Rochem International Inc, 1 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 BASF

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders, 24 Direct Compression, 14 Chewable & Orodispersible Aids, 13 Taste Masking, 12 Co-Processed Excipients, 11 Thickeners and Stabilizers, 10 Lubricants & Glidants, 9 Disintegrants & Superdisintegrants, 9 Granulation, 5 Controlled & Modified Release, 3 Coating Systems & Additives, 3 Parenteral, 1 Rheology Modifiers, 1 Emulsifying Agents, 1 Film Formers & Plasticizers, 1 API Stability Enhancers